Premium
Streptococcus agalactiae Infection in Domestic Rabbits, Oryctolagus cuniculus
Author(s) -
Ren S. Y.,
Geng Y.,
Wang K. Y.,
Zhou Z. Y.,
Liu X. X.,
He M.,
Peng X.,
Wu C. Y.,
Lai W. M.
Publication year - 2014
Publication title -
transboundary and emerging diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.392
H-Index - 63
eISSN - 1865-1682
pISSN - 1865-1674
DOI - 10.1111/tbed.12073
Subject(s) - streptococcus agalactiae , biology , microbiology and biotechnology , ampicillin , amoxicillin , gentamicin , group b , penicillin , respiratory distress , tetracycline , antibiotics , streptococcus , bacteria , medicine , genetics , anesthesia
Streptococcus agalactia e (Group B streptococcus, GBS ) has emerged as an important pathogen that affects humans and animals, including aquatic species. In August 2011, a severe infectious disease affecting rabbits, which caused 42% mortality, occurred in M ianyang, S ichuan Province, C hina. The main clinical signs included acute respiratory distress syndrome, fever, paddling and convulsions. A Gram‐positive, chain‐forming coccus was isolated from the primary organs and tissues of diseased rabbits and then identified as S . agalactiae by morphology, biochemical and physiological characteristics, 16 S r DNA and gyr B gene sequences analysis. All isolates of S . agalactiae showed a similar antibiotic susceptibility, which were sensitive to florfenicol, ampicillin,gentamicin and norfloxacin, as well as being resistant to penicillin, amoxicillin and tetracycline. To our knowledge, this is the first report on S . agalactiae natural infection in domestic rabbits.